UnitedHealth Group Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year) decreased by 4.3% to $3.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.7%, from $3.69B to $3.33B. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong short-term liquidity, while lower levels might suggest a reliance on other funding sources or a strategy to reinvest in longer-term assets.
This metric measures the amortized cost of available-for-sale debt securities that are scheduled to mature within one ye...
Standard metric for all financial institutions to demonstrate short-term solvency and cash flow management.
afs_debt_securities_amortized_cost_1y| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.81B | $2.87B | $2.99B | $3.44B | $3.84B | $4.72B | $4.65B | $5.37B | $4.43B | $5.17B | $4.88B | $3.69B | $3.53B | $3.49B | $3.33B |
| QoQ Change | — | +2.2% | +4.0% | +15.1% | +11.7% | +23.0% | -1.6% | +15.6% | -17.5% | +16.7% | -5.6% | -24.3% | -4.4% | -1.3% | -4.3% |
| YoY Change | — | — | — | +22.5% | +33.8% | +58.1% | +35.1% | +39.9% | -6.2% | +11.3% | -9.1% | -16.6% | -31.7% | -28.6% | -9.7% |